Matthew Kaplan
Stock Analyst at Ladenburg Thalmann
(2.81)
# 1,910
Out of 4,983 analysts
26
Total ratings
62.5%
Success rate
18.46%
Average return
Main Sectors:
Stocks Rated by Matthew Kaplan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| UTHR United Therapeutics | Maintains: Buy | $319 → $344 | $397.97 | -13.56% | 9 | Oct 31, 2024 | |
| URGN UroGen Pharma | Maintains: Buy | $48 → $54 | $18.07 | +196.07% | 1 | Jun 14, 2024 | |
| TGTX TG Therapeutics | Maintains: Buy | $39 → $40 | $31.99 | +25.04% | 3 | May 2, 2024 | |
| LQDA Liquidia | Maintains: Buy | $15 → $30 | $26.03 | +15.25% | 2 | Dec 21, 2023 | |
| ARDX Ardelyx | Maintains: Buy | $7.5 → $8.5 | $6.42 | +32.40% | 4 | Aug 3, 2023 | |
| AVDL Avadel Pharmaceuticals | Maintains: Buy | $15 → $16 | $15.41 | +3.83% | 1 | May 2, 2023 | |
| KPRX Kiora Pharmaceuticals | Reiterates: Buy | $1,071 | $2.65 | +40,315.09% | 2 | Feb 8, 2023 | |
| XAIR Beyond Air | Maintains: Buy | $340 → $460 | $2.42 | +18,908.26% | 1 | Jun 29, 2022 | |
| LPCN Lipocine | Upgrades: Buy | $51 | $2.96 | +1,622.97% | 1 | Dec 10, 2020 | |
| COGT Cogent Biosciences | Initiates: Buy | $16 | $12.54 | +27.59% | 1 | Oct 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $45 | $3.07 | +1,365.80% | 1 | Jan 22, 2020 |
United Therapeutics
Oct 31, 2024
Maintains: Buy
Price Target: $319 → $344
Current: $397.97
Upside: -13.56%
UroGen Pharma
Jun 14, 2024
Maintains: Buy
Price Target: $48 → $54
Current: $18.07
Upside: +196.07%
TG Therapeutics
May 2, 2024
Maintains: Buy
Price Target: $39 → $40
Current: $31.99
Upside: +25.04%
Liquidia
Dec 21, 2023
Maintains: Buy
Price Target: $15 → $30
Current: $26.03
Upside: +15.25%
Ardelyx
Aug 3, 2023
Maintains: Buy
Price Target: $7.5 → $8.5
Current: $6.42
Upside: +32.40%
Avadel Pharmaceuticals
May 2, 2023
Maintains: Buy
Price Target: $15 → $16
Current: $15.41
Upside: +3.83%
Kiora Pharmaceuticals
Feb 8, 2023
Reiterates: Buy
Price Target: $1,071
Current: $2.65
Upside: +40,315.09%
Beyond Air
Jun 29, 2022
Maintains: Buy
Price Target: $340 → $460
Current: $2.42
Upside: +18,908.26%
Lipocine
Dec 10, 2020
Upgrades: Buy
Price Target: $51
Current: $2.96
Upside: +1,622.97%
Cogent Biosciences
Oct 14, 2020
Initiates: Buy
Price Target: $16
Current: $12.54
Upside: +27.59%
Jan 22, 2020
Initiates: Buy
Price Target: $45
Current: $3.07
Upside: +1,365.80%